Enoblituzumab (Anti-B7-H3 / CD276), 1mg*5

Enoblituzumab (Anti-B7-H3 / CD276), 1mg*5

Anti-Complement C5aR1 (G2_anti-C5aR), 1mg

Anti-Complement C5aR1 (G2_anti-C5aR), 1mg

Enoblituzumab (Anti-B7-H3 / CD276), 1mg*25

19.336,31 RON
SKU
SKM_A2626_1mg*25

Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1κ monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC). MW :150 KD.

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1κ monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC). MW :150 KD.